Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805059 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT05805059: Completed NA study, sponsored by CooperVision.
NCT05805059 is a NA study that has completed, run by CooperVision. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05805059, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.
Primary Outcome
Lens Handling on Removal, using a 0-100 scale (0=Very difficult, 100=Very easy)
Interventions
- DEVICE Control Contact Lens (stenfilcon A)
- DEVICE Test Contact Lens (senofilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2023-04-14 |
| Est. Completion | 2023-06-20 |
| Phase | NA |
What the finished NCT05805059 record still lists
NCT05805059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Contact Lens (stenfilcon A) is the first listed.
NCT05805059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05805059 about?
NCT05805059 is a clinical study titled "Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses". The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.
What is the current status of trial NCT05805059?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2023-04-14. Estimated completion is 2023-06-20.
What interventions are being tested in trial NCT05805059?
The interventions under investigation include: Control Contact Lens (stenfilcon A) (DEVICE), Test Contact Lens (senofilcon A) (DEVICE).
Who is sponsoring clinical trial NCT05805059?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05805059's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI